Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-26-000006

CEO and CFO bought 2,900 shares at $21.73 ($63,017)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2025-12-30 Purchase +2,900 $21.73 $63,017 5,595,102 D: show line 1 in the form
Open-market purchases · 2,900 sh · avg $21.73 · $63,017
Loading xslF345X05/ownership.xml…